Inside Intensive Care: Real World Stories in Implementing Continuous Beta-lactams in Critical Care

Sura Ali

Highly Specialist Pharmacist, Lancashire Teaching Hospitals

Sura is a Highly Specialist Pharmacist at Lancashire Teaching Hospitals, a 34 bedded unit. Her specialist interests are delivering high standards of care, pharmacogenomics, antimicrobial stewardship and delirium management in the emerging Neurodiverse population of patients, in particular. Sura endeavours to collaboratively promote the path of best practise through education, promotion of our invaluable ICS workstreams and standards, as well as work with our pharmacist members on innovation.

Dr Andrew Conway-Morris

Consultant Intensivist, University of Cambridge/Addenbrooke’s Hospital

Dr Conway Morris is a critical care consultant and MRC Clinician Scientist based at the University of Cambridge.  He trained at the Universities of Glasgow and Edinburgh, undertaking a PhD in Edinburgh focused on immune failure in critical illness and nosocomial infection.  His research interests include neutrophil function and dysfunction in critical illness, where he identified complement component C5a as a key driver of dysfunction in patients.  He has also developed and tested a number of diagnostics for pneumonia, using both host and pathogen-focussed techniques.  His animating force is a desire to improve the management of infection in intensive care, and combat the rising tide of antimicrobial resistance.  He was recently awarded the Royal College of Anaesthetists 2023 Mackintosh Professorship.   He is the director of the European Society of Intensive Care Medicine’s research and antimicrobial stewardship learning pathways.

: @andymoz78

Reena Mehta

Consultant Pharmacist, King’s College Hospital NHS Foundation Trust & Chair of ICS Learning Division

Reena is a Consultant Pharmacist in Critical Care at King’s College Hospital NHS Foundation Trust, London and Chair of the Intensive Care Society’s Learning Division.

Her specialist areas of interest are anti-microbial stewardship, medicines use in extra-corporeal circuits and health inequalities. 

She has worked in Critical Care for over 15 years, and has co-authored and provided specialist input nationally into areas such as pharmacy critical care workforce, clinical guidelines, and advanced critical care training.  Reena is an Associate Editor for the Journal of the Intensive Care Society and an Honorary Senior Lecturer at King’s College London.   Within her organisation, she is a Principal Investigator on a number of CRN Portfolio studies

Reena is also the Pharmacy Lead for the South East London ICS - Critical Care/ODN and a member of the United Kingdom Adult Critical Care Pharmacy Leadership Forum.  She has recently completed an MSc in Health Economics, Policy & Management at the London School of Economics and Political Science. 

: @ReenaM2703

Adam Riedlinger

Senior Practice Development Nurse for Adult Critical Care, King's College Hospital NHS Foundation Trust

Adam Riedlinger is a Senior Practice Development Nurse for Adult Critical Care at King's College Hospital NHS Foundation Trust, with a specialist background in liver care, critical care education, and digital healthcare transformation. He is passionate about improving patient outcomes through evidence-based practice, workforce development, and the effective implementation of clinical information systems. Adam has led initiatives in nursing education, competency development, quality improvement, and electronic health record optimisation, with a growing clinical academic interest in the intersection of nursing practice, digital innovation, and implementation science.

David Sapsford

Consultant Pharmacist , Cambridge University Hospitals NHSFT, Pharmacy PAG Chair

David has been practising critical care pharmacy since 2003 and now leads a team of ten pharmacists and a pharmacy technician covering the 59 adult critical care beds at Cambridge University Hospitals NHSFT. His particular interests include safe, effective use and stewardship of antimicrobials, and management of pain and delirium in ICU patients.

David is deputy chair of the Intensive Care Society Pharmacy Professional Advisory Group and is delighted to count himself as inaugural ICS Leadership Programme alumni.